Kiora Pharmaceuticals, Inc. (KPRX)

Investor Presentation

View our latest Investor Presentation to find the most recent investor-related information.

Latest News

View All News

February 13, 2025 7:00 AM EST

Kiora Pharmaceuticals Secures U.S. Composition-of-Matter Patent Expanding Protection of Its Anti-Inflammatory Compound KIO-104

Feb 11, 2025 6:45 am EST

Kiora Receives Approval to Initiate KLARITY, a Phase 2 Clinical Trial of KIO-104 for the Treatment of Retinal Macular Edema

Nov 8, 2024 7:00 am EST

Kiora Pharmaceuticals Reports Third Quarter Results; Retinal Disease Pipeline Advancing Two Phase 2 Studies

Oct 29, 2024 6:45 am EDT

Kiora Pharmaceuticals Receives Investigational New Drug Approval to Initiate ABACUS-2, a Phase 2 Clinical Trial of KIO-301 for the Treatment of Retinitis Pigmentosa

View All News

Latest Presentation

Jan 6, 2025 Kiora Corporate Overview January 2025

View All Presentations

Company Overview

Kiora Pharmaceuticals (NASDAQ: KPRX) is a clinical-stage biopharmaceutical company developing advanced treatments for retinal disease. Our strategy is to target critical pathways underlying eye disease with innovative small molecules to preserve, slow, or restore vision loss.

View Executive Team

Latest Financial Results

Q3 2024

Quarter Ended Sep 30, 2024

View All Financial Results

Earnings Release

10-Q XBRL Zip

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2023

View 10-K

IR Contacts

Headquarters

Kiora Pharmaceuticals, Inc.
332 Encinitas Boulevard
Suite 102
Encinitas, CA 92024

Investor Relations

investors@kiorapharma.com

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.